Songji Biotech Launches 1,000-Dalton Marine Peptides Backed by Hualien Tzu Chi Hospital Research Collaboration
Songji Biotech Enterprise Co., Ltd. (SGBE) has announced the commercial launch of standardized 1,000-Dalton marine collagen peptides, scientifically validated for anti-aging efficacy through a collaborative study with Hualien Tzu Chi Hospital. Derived from sustainable milkfish scales using proprietary enzymatic hydrolysis technology, these low-molecular-weight peptides are engineered to overcome transdermal absorption barriers. SGBE supports the global market through its proprietary brand, Fishelton, and provides comprehensive OEM/ODM services from its ISO 22716 and GMP-certified facilities. Taiwan, Taiwan, 27th Jan 2026 – Songji
Read more